Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Navamedic ASA ( (DE:N1A) ) is now available.
Navamedic ASA has successfully completed a rights issue, raising NOK 130 million through the oversubscription of 6,473,136 offer shares, exceeding the initial offer by 7%. This capital increase is expected to enhance the company’s financial stability and support its growth strategy in the healthcare sector, with the new shares anticipated to begin trading on Euronext Oslo Børs by mid-October 2025.
More about Navamedic ASA
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. The company leverages its scalable market access platform, category competence, and local knowledge to meet specific medical needs of patients and consumers. Navamedic operates in the Nordic countries, the Baltics, Benelux, and has sales representation in Greece. It is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange.
YTD Price Performance: -14.93%
Average Trading Volume: 14,542
Current Market Cap: NOK509.7M
Learn more about N1A stock on TipRanks’ Stock Analysis page.